A federal judge in Chicago has dismissed a shareholder lawsuit accusing Abbott Laboratories of misleading investors about problems at the company's infant formula plant before and after a major 2022 recall, finding that the allegations did not adequately show the fraudulent intent required under federal securities law.U.S. District Judge Steven... Read More »